Articles by Molly Li, MBBS
The study participants include those who have had at least one first-degree relative diagnosed with lung cancer.
The trial is evaluating perioperative pembrolizumab plus sacituzumab govitecan for certain patients with NSCLC.
Dr. Li discusses important thoracic oncology data presented at the ESMO 2024 Congress, which was held in Barcelona, Spain
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.